Published in Cardiovasc Diabetol on January 10, 2012
Review of hyperuricemia as new marker for metabolic syndrome. ISRN Rheumatol (2014) 1.08
Cystatin C and asymptomatic coronary artery disease in patients with metabolic syndrome and normal glomerular filtration rate. Cardiovasc Diabetol (2012) 0.92
Association between serum uric acid levels and cardiovascular disease in middle-aged and elderly Chinese individuals. BMC Cardiovasc Disord (2014) 0.90
Relationship between serum uric acid and internal carotid resistive index in hypertensive women: a cross-sectional study. BMC Cardiovasc Disord (2012) 0.89
Mildly elevated serum bilirubin levels are negatively associated with carotid atherosclerosis among elderly persons. PLoS One (2014) 0.85
Correlation between serum uric Acid and renal function in patients with stable coronary artery disease and type 2 diabetes. J Clin Med Res (2014) 0.83
Serum uric acid levels are associated with hypertension and metabolic syndrome but not atherosclerosis in Chinese inpatients with type 2 diabetes. J Hypertens (2015) 0.80
Risk factors for incident hyperuricemia during mid-adulthood in African American and white men and women enrolled in the ARIC cohort study. BMC Musculoskelet Disord (2013) 0.79
Rationale and design of a multicenter randomized study for evaluating vascular function under uric acid control using the xanthine oxidase inhibitor, febuxostat: the PRIZE study. Cardiovasc Diabetol (2016) 0.78
Asymptomatic hyperuricemia is independently associated with coronary artery calcification in the absence of overt coronary artery disease: A single-center cross-sectional study. Medicine (Baltimore) (2017) 0.76
Interactive association of serum uric acid and total bilirubin with renal dysfunction among community-dwelling subjects. Int Urol Nephrol (2017) 0.75
Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem (1972) 95.79
Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation (2005) 43.74
Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation (2005) 8.54
New criteria for 'obesity disease' in Japan. Circ J (2002) 6.19
Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992. National Health and Nutrition Examination Survey. JAMA (2000) 6.10
Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2. Hypertension (2003) 3.39
Uric acid transport and disease. J Clin Invest (2010) 2.33
Uric acid: A marker of increased cardiovascular risk. Atherosclerosis (2008) 2.23
Ultrasonographically assessed carotid morphology and the risk of coronary heart disease. Arterioscler Thromb (1991) 2.11
Uric acid metabolism and tubular sodium handling. Results from a population-based study. JAMA (1993) 2.10
Effects of statin treatment on uric acid homeostasis in patients with primary hyperlipidemia. Am Heart J (2004) 2.09
Uric acid and the development of metabolic syndrome in women and men. Metabolism (2008) 2.09
Uric acid as a mediator of endothelial dysfunction, inflammation, and vascular disease. Semin Nephrol (2005) 2.07
Elevated serum uric acid levels in metabolic syndrome: an active component or an innocent bystander? Metabolism (2006) 2.01
Uric acid and serum antioxidant capacity: a reaction to atherosclerosis? Atherosclerosis (2000) 1.92
Hyperuricemia as a mediator of the proinflammatory endocrine imbalance in the adipose tissue in a murine model of the metabolic syndrome. Diabetes (2011) 1.82
Association between serum uric acid, metabolic syndrome, and carotid atherosclerosis in Japanese individuals. Arterioscler Thromb Vasc Biol (2005) 1.82
Serum uric acid and the risk for hypertension and Type 2 diabetes in Japanese men: The Osaka Health Survey. J Hypertens (2001) 1.75
Relation between serum uric acid and carotid intima-media thickness in healthy postmenopausal women. Intern Emerg Med (2007) 1.72
Correlates of uric acid and its association with asymptomatic carotid atherosclerosis: the ARIC Study. Atherosclerosis Risk in Communities. Ann Epidemiol (1996) 1.65
Metabolic syndrome and cardiovascular disease in older people: The cardiovascular health study. J Am Geriatr Soc (2006) 1.59
Serum uric acid level and its association with metabolic syndrome and carotid atherosclerosis in patients with type 2 diabetes. Cardiovasc Diabetol (2011) 1.45
Prevalence and determinants of carotid atherosclerosis in a general population. Stroke (1992) 1.38
Drinking and its relation to smoking, BP, blood lipids, and uric acid. The Framingham study. Arch Intern Med (1983) 1.37
Prevalence of the metabolic syndrome using the modified ATP III definitions for workers in Japan, Korea and Mongolia. J Occup Health (2005) 1.26
Uric acid and coronary heart disease risk: evidence for a role of uric acid in the obesity-insulin resistance syndrome. The Normative Aging Study. Am J Epidemiol (1995) 1.23
Serum uric acid is associated with carotid plaques: the National Heart, Lung, and Blood Institute Family Heart Study. J Rheumatol (2009) 1.11
Relationship between serum uric acid concentration, metabolic syndrome and carotid atherosclerosis. Intern Med (2006) 1.11
Absence of an association between serum uric acid and mortality from cardiovascular disease: NIPPON DATA 80, 1980-1994. National Integrated Projects for Prospective Observation of Non-communicable Diseases and its Trend in the Aged. Eur J Epidemiol (2001) 1.05
A simple and reproducible method for assessing intimal-medial thickness of the common carotid artery. Br J Radiol (1997) 1.05
Uric acid level and its association with carotid intima-media thickness in patients with hypertension. Atherosclerosis (2007) 1.02
The relationship between serum uric acid level and metabolic syndrome: differences by sex and age in Taiwanese. J Epidemiol (2010) 1.02
Diabetes associated with a low serum uric acid level in a general Chinese population. Diabetes Res Clin Pract (2006) 1.00
Hormonal and cytokine effects of uric acid. Curr Opin Nephrol Hypertens (2006) 1.00
Preobesity in World Health Organization classification involves the metabolic syndrome in Japanese. Diabetes Care (2002) 0.89
Associations between carotid atherosclerosis and high factor VIII activity, dyslipidemia, and hypertension. Stroke (1997) 0.84
Reproducibility of high-sensitivity C-reactive protein as an inflammatory component of metabolic syndrome in Japanese. Circ J (2010) 0.82
Real-time tissue elastography for evaluation of hepatic fibrosis and portal hypertension in nonalcoholic fatty liver diseases. Hepatology (2012) 2.27
Body mass index is the most useful predictive factor for the onset of nonalcoholic fatty liver disease: a community-based retrospective longitudinal cohort study. J Gastroenterol (2012) 2.03
Abdominal imaging findings of a patient with hepatocellular carcinoma associated with glycogen storage disease type 1a. Intern Med (2011) 1.91
High PD-L1/CD86 ratio on plasmacytoid dendritic cells correlates with elevated T-regulatory cells in liver transplant tolerance. Transplantation (2008) 1.85
An association between decreased estimated glomerular filtration rate and arterial stiffness. Intern Med (2008) 1.75
Early development of primary biliary cirrhosis in female C57BL/6 mice because of poly I:C administration. Liver Int (2005) 1.69
Infection and dysfunction of circulating blood dendritic cells and their subsets in chronic hepatitis C virus infection. J Gastroenterol (2004) 1.68
Characteristics of small bowel tumors detected by double balloon endoscopy. Dig Dis Sci (2011) 1.63
Impaired dendritic cell function resulting from chronic undernutrition disrupts the antigen-specific immune response in mice. J Nutr (2007) 1.60
Unc93B1 restricts systemic lethal inflammation by orchestrating Toll-like receptor 7 and 9 trafficking. Immunity (2011) 1.59
Dietary habits and nutrient intake in non-alcoholic steatohepatitis. Nutrition (2006) 1.54
General rules for recording endoscopic findings of esophagogastric varices (2nd edition). Dig Endosc (2010) 1.51
Des-gamma-carboxy prothrombin identified by P-11 and P-16 antibodies reflects prognosis for patients with hepatocellular carcinoma. J Gastroenterol Hepatol (2013) 1.49
A scoring system for primary biliary cirrhosis and its application for variant forms of autoimmune liver disease. J Gastroenterol (2003) 1.46
Association between subclinical hypothyroidism and diabetic nephropathy in patients with type 2 diabetes mellitus. Endocr J (2014) 1.44
Esophagogastric varices as a prognostic factor for the determination of clinical stage in patients with primary biliary cirrhosis. J Gastroenterol (2003) 1.44
Influence of genotypes and precore mutations on fulminant or chronic outcome of acute hepatitis B virus infection. Hepatology (2006) 1.43
Induction and maintenance of anti-HBs in immunosuppressed murine hepatitis B virus carriers by a novel vaccination approach: implications for use in hepatitis B virus-infected subjects with liver transplantation. J Gastroenterol (2004) 1.39
Combination therapy with interferon-alpha and ribavirin as immunomodulators in patients with chronic hepatitis C. J Gastroenterol (2003) 1.39
Plasma resistin, associated with single nucleotide polymorphism -420, is correlated with insulin resistance, lower HDL cholesterol, and high-sensitivity C-reactive protein in the Japanese general population. Diabetes Care (2007) 1.34
Replication study of candidate genes associated with type 2 diabetes based on genome-wide screening. Diabetes (2008) 1.33
Genome-wide association study identifies TNFSF15 and POU2AF1 as susceptibility loci for primary biliary cirrhosis in the Japanese population. Am J Hum Genet (2012) 1.32
The sphingosine-1-phosphate receptor agonist FTY720 modulates dendritic cell trafficking in vivo. Am J Transplant (2005) 1.32
Liver fibrosis in patients with chronic hepatitis C: noninvasive diagnosis by means of real-time tissue elastography--establishment of the method for measurement. Radiology (2011) 1.30
Common variants in the ATP2B1 gene are associated with susceptibility to hypertension: the Japanese Millennium Genome Project. Hypertension (2010) 1.26
Chiral blastomere arrangement dictates zygotic left-right asymmetry pathway in snails. Nature (2009) 1.26
Anti-HBs-positive liver failure due to hepatitis B virus reactivation induced by rituximab. Intern Med (2006) 1.23
Etiology of liver cirrhosis in Japan: a nationwide survey. J Gastroenterol (2009) 1.16
Detection of hepatitis C virus (HCV) in serum and peripheral-blood mononuclear cells from HCV-monoinfected and HIV/HCV-coinfected persons. J Infect Dis (2005) 1.14
Low TLR4 expression by liver dendritic cells correlates with reduced capacity to activate allogeneic T cells in response to endotoxin. J Immunol (2005) 1.14
The dipeptidyl peptidase-4 (DPP-4) inhibitor vildagliptin improves glycemic control in type 2 diabetic patients undergoing hemodialysis. Endocr J (2011) 1.13
Guidelines for the treatment of chronic hepatitis and cirrhosis due to hepatitis C virus infection for the fiscal year 2008 in Japan. Hepatol Res (2010) 1.13
Soluble CD163 in patients with liver diseases: very high levels of soluble CD163 in patients with fulminant hepatic failure. J Gastroenterol (2005) 1.12
A technique for the measurement of visceral fat by ultrasonography: comparison of measurements by ultrasonography and computed tomography. Intern Med (2005) 1.12
Infusion of stably immature monocyte-derived dendritic cells plus CTLA4Ig modulates alloimmune reactivity in rhesus macaques. Transplantation (2007) 1.10
Drug-induced hepatitis due to repeated use of hair dye. Intern Med (2003) 1.10
Poor allostimulatory function of liver plasmacytoid DC is associated with pro-apoptotic activity, dependent on regulatory T cells. J Hepatol (2008) 1.10
Ethanol affects the generation, cosignaling molecule expression, and function of plasmacytoid and myeloid dendritic cell subsets in vitro and in vivo. J Leukoc Biol (2006) 1.09
Dendritic cells, the liver, and transplantation. Hepatology (2007) 1.09
The GCKR rs780094 polymorphism is associated with susceptibility of type 2 diabetes, reduced fasting plasma glucose levels, increased triglycerides levels and lower HOMA-IR in Japanese population. J Hum Genet (2010) 1.08
Effect of genetic polymorphism of OATP-C (SLCO1B1) on lipid-lowering response to HMG-CoA reductase inhibitors. Drug Metab Pharmacokinet (2004) 1.07
Drug-induced liver injury in Japan: An analysis of 1676 cases between 1997 and 2006. Hepatol Res (2009) 1.05
BCAA-enriched snack improves nutritional state of cirrhosis. Nutrition (2007) 1.05
Present status of autoimmune hepatitis in Japan: a nationwide survey. J Gastroenterol (2011) 1.05
Phase I/II study of immunotherapy using tumor antigen-pulsed dendritic cells in patients with hepatocellular carcinoma. Int J Oncol (2012) 1.04
Protein kinase R is increased and is functional in hepatitis C virus-related hepatocellular carcinoma. Am J Gastroenterol (2003) 1.03
High-sensitivity C-reactive protein and gamma-glutamyl transferase levels are synergistically associated with metabolic syndrome in community-dwelling persons. Cardiovasc Diabetol (2010) 1.02
Expression of CD163 in the liver of patients with viral hepatitis. Pathol Res Pract (2005) 1.02
Development of novel magnetic nano-carriers for high-performance affinity purification. Colloids Surf B Biointerfaces (2008) 1.01
No association between INSIG2 Gene rs7566605 polymorphism and being overweight in Japanese population. Obesity (Silver Spring) (2008) 1.01
Molecular characterization and distribution of motilin family receptors in the human gastrointestinal tract. J Gastroenterol (2006) 0.99
B cell-activating factor controls the production of adipokines and induces insulin resistance. Obesity (Silver Spring) (2011) 0.99
Heart allograft protection with low-dose carbon monoxide inhalation: effects on inflammatory mediators and alloreactive T-cell responses. Transplantation (2006) 0.99
Extracting task-related activation components from optical topography measurement using independent components analysis. J Biomed Opt (2008) 0.98
Percutaneous ultrasound-guided radiofrequency ablation of hepatocellular carcinoma with artificially induced pleural effusion and ascites. J Gastroenterol (2007) 0.98
Predictive values of amino acid sequences of the core and NS5A regions in antiviral therapy for hepatitis C: a Japanese multi-center study. J Gastroenterol (2009) 0.97
Activation and maturation of antigen-presenting dendritic cells during vaccine therapy in patients with chronic hepatitis due to hepatitis B virus. Hepatol Res (2002) 0.97
Assessment of 287 Japanese cases of drug induced liver injury by the diagnostic scale of the International Consensus Meeting. Hepatol Res (2003) 0.97
Hepatic safety profile and glycemic control of pioglitazone in more than 20,000 patients with type 2 diabetes mellitus: postmarketing surveillance study in Japan. Diabetes Res Clin Pract (2006) 0.97
Regulatory dendritic cells pulsed with carbonic anhydrase I protect mice from colitis induced by CD4+CD25- T cells. J Immunol (2012) 0.97
Fucosylated fraction of alpha-fetoprotein as a predictor of prognosis in patients with hepatocellular carcinoma after curative treatment. Dig Dis Sci (2010) 0.97
Virtual sonographic radiofrequency ablation of hepatocellular carcinoma visualized on CT but not on conventional sonography. AJR Am J Roentgenol (2006) 0.97
Comparison of genotypes C and D of the hepatitis B virus in Japan: a clinical and molecular biological study. J Med Virol (2004) 0.96
In vivo immunization by vaccine therapy following virus suppression by lamivudine: a novel approach for treating patients with chronic hepatitis B. J Clin Virol (2005) 0.96
Safety and efficacy of hepatitis B surface antigen-pulsed dendritic cells in human volunteers. Hepatol Res (2004) 0.96
Production and efficacy of a dendritic cell-based therapeutic vaccine for murine chronic hepatitis B virus carrierer. Int J Mol Med (2004) 0.95
Hepatic encephalopathy due to intrahepatic portosystemic venous shunt successfully treated by interventional radiology. Intern Med (2005) 0.95
Recent clinical features of Wilson's disease with hepatic presentation. J Gastroenterol (2004) 0.95
Long-term outcome of Japanese patients with type 1 autoimmune hepatitis. Hepatology (2012) 0.95
Primary biliary cirrhosis - Autoimmune hepatitis overlap syndrome: A rationale for corticosteroids use based on a nation-wide retrospective study in Japan. Hepatol Res (2011) 0.94
Reduced high-molecular-weight adiponectin and elevated high-sensitivity C-reactive protein are synergistic risk factors for metabolic syndrome in a large-scale middle-aged to elderly population: the Shimanami Health Promoting Program Study. J Clin Endocrinol Metab (2007) 0.93
Genetic variation in CDH13 is associated with lower plasma adiponectin levels but greater adiponectin sensitivity in East Asian populations. Diabetes (2013) 0.93
Autoimmune hepatitis associated with Graves' disease. Intern Med (2003) 0.93
Existence of TT virus DNA and TTV-like mini virus DNA in infant cord blood: mother-to-neonatal transmission. Hepatol Res (2001) 0.92
An association between the estimated glomerular filtration rate and carotid atherosclerosis. Intern Med (2008) 0.92
Alanine aminotransferase/aspartate aminotransferase ratio is the best surrogate marker for insulin resistance in non-obese Japanese adults. Cardiovasc Diabetol (2012) 0.92
Relationships between lipid profiles and metabolic syndrome, insulin resistance and serum high molecular adiponectin in Japanese community-dwelling adults. Lipids Health Dis (2011) 0.92
High efficiency Hall effect micro-biosensor platform for detection of magnetically labeled biomolecules. Biosens Bioelectron (2006) 0.92